Meeting
2018 ASCO Annual Meeting
Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC).
Authors
Rahul K Das
GNS Healthcare, Cambridge, MA
Rahul K Das , Leon Furchtgott , Jeffrey A. Meyerhardt , Andrew B. Nixon , Federico Innocenti , Daniel Cunha , Kelly Rich , Heinz-Josef Lenz , Donna Niedzwiecki , Eileen Mary O'Reilly , Fang-Shu Ou , Jeanne Latourelle , Diane Wuest , Boris Hayete , Iya Khalil , Alan P. Venook
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
U10CA180821, U10CA180882
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3570)
DOI
10.1200/JCO.2018.36.15_suppl.3570
Abstract #
3570
Poster Bd #
63
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.
First Author: Sandra Algaze
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).
First Author: Karam Ashouri
Poster
2022 ASCO Annual Meeting
Predictive value of MAOB gene expression for targeted therapy in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB (Alliance)/SWOG 80405.
First Author: Wu Zhang
Poster
2019 Gastrointestinal Cancers Symposium
On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance).
First Author: Ace Joseph Hatch